Svoronos Dawn

Director at XENE; Director at Global Blood Therapeutics, Inc.; Director at PTCT, and 1 more

Sold, on record
$2.3M
Dollars the filings state
Form 4 sales
12
Latest Aug 24, 2023
Form 144 notices
1
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale PTCTPlan not stated
    Feb 1 2021

    Sold 506 shares at $56.96 ($29k)

    Svoronos Dawn, Director

    Sold 1.8% of holdings ($1.6M position)27,430 shares leftFiling

  2. 2 Form 4 sale PTCTPlan not stated
    Jun 9 +128 days

    Sold 365 shares at $41.89 ($15k)

    Svoronos Dawn, Director

    Sold 1.3% of holdings ($1.1M position)27,065 shares leftFiling

  3. 3 Form 4 sale Global Blood Therapeutics, Inc.Unusual
    Jun 18 +9 days

    Sold 1,609 shares at $36.54 ($59k)

    Svoronos Dawn, Director

    Sold 30.4% of holdings ($193k position)3,684 shares leftFiling

  4. 4 Form 4 sale PTCTPlan not stated
    Jan 7 +203 days

    Sold 510 shares at $38.53 ($20k)

    Svoronos Dawn, Director

    Sold 1.9% of holdings ($1M position)26,555 shares left1.4x usual sizeFiling

  5. 5 Form 4 sale PTCTPlan not stated
    Jun 9 +153 days

    Sold 738 shares at $27.20 ($20k)

    Svoronos Dawn, Director

    Sold 2.5% of holdings ($809k position)29,017 shares left1.7x usual sizeFiling

  6. 6 Form 4 sale Global Blood Therapeutics, Inc.Unusual
    Jun 21 +12 days

    Sold 1,908 shares at $27.24 ($52k)

    Svoronos Dawn, Director

    Sold 26.2% of holdings ($198k position)5,376 shares leftFiling

  7. 7 Form 144 notice XENENotice
    Aug 24 +429 days

    Filed to sell 25,000 shares ($968k)

    Svoronos Dawn, Director

    No 10b5-1 planFirst sale on recordFiling

  8. 8 Form 4 sale XENEUnusual
    Aug 24 same day

    Sold 25,000 shares at $38.70 ($968k)

    Svoronos Dawn, Director

    No 10b5-1 planSold 50% of holdings ($1.9M position)25,000 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Svoronos Dawn
Source
Aug 24, 2023XENEDirectorForm 4 sale25,000$968k50.0%UnusualSEC
Aug 24, 2023XENEDirectorForm 144 notice25,000$968kNoticeSEC
Jun 21, 2022Global Blood Therapeutics, Inc.DirectorForm 4 sale1,908$52k26.2%UnusualSEC
Jun 9, 2022PTCTDirectorForm 4 sale738$20k2.5%Plan not statedSEC
Jan 7, 2022PTCTDirectorForm 4 sale510$20k1.9%Plan not statedSEC
Jun 18, 2021Global Blood Therapeutics, Inc.DirectorForm 4 sale1,609$59k30.4%UnusualSEC
Jun 9, 2021PTCTDirectorForm 4 sale365$15k1.3%Plan not statedSEC
Feb 1, 2021PTCTDirectorForm 4 sale506$29k1.8%Plan not statedSEC
Jun 19, 2020Global Blood Therapeutics, Inc.DirectorForm 4 sale2,544$163k53.0%UnusualSEC
Jun 11, 2020PTCTDirectorForm 4 sale364$18k1.4%Plan not statedSEC
Mar 14, 2016MEDIVATION, INC.DirectorForm 4 sale6,000$233k24.8%Plan not statedSEC
Sep 8, 2015MEDIVATION, INC.DirectorForm 4 sale3,100$276k20.4%Plan not statedSEC
Mar 2, 2015MEDIVATION, INC.DirectorForm 4 sale3,350$401k19.7%Plan not statedSEC